Endothelial cell activation, injury, damage and dysfunction: Separate entities or mutual terms?

Blood Coagulation and Fibrinolysis

Volumn 11, Issue 7, 2000, Pages 623-630

  Blann, A D ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Activation; Cytokines; Damage; Endothelium

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE;

ARTICLE; CELL ACTIVATION; CELL DAMAGE; CELL DEATH; CELL FUNCTION; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; EDEMA; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFARCTION; PATHOGENESIS; PRIORITY JOURNAL; SMOKING; THROMBOSIS;

ANIMALS; APOPTOSIS; CYTOKINES; ENDOTHELIUM, VASCULAR; HUMANS; VASCULAR DISEASES;

EID: 0033755958     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200010000-00006     Document Type: Article

References (69)

1. Endothelial cells in physiology and in the pathophysiology of vascular disorders
2. Regulatory functions of the vascular endothelium
3. Cell biology of endothelial cells
4. Cytokine-mediated activation of vascular endothelium
5. Cytokines as communication signals between leukocytes and endothelial cells
6. Leucocyte-endothelial interactions and regulation of leucocyte migration
7. Cytokine activation of endothelial cells: New molecules for an old paradigm
8. Ia expression by vascular endothelium is inducible by activated T cells and by human interferon
9. Endothelial cell activation. A central pathophysiological process
10. Vascular factors and thrombosis
11. The role of blood and platelets in atherosclerosis and the complications of atherosclerosis
12. Cell biology of atherosclerosis
13. Is atherosclerosis an immunologically mediated disease?
14. The endothelium in atherothrombotic disease: Assessment of function, mechanisms and clinical implications
15. Infection, inflammation and infarction: Does acute endothelial dysfunction provide a link?
16. Von Willebrand factor is an acute phase reactant in man
17. The acute phase response
18. Pathogenesis of systemic sclerosis: A vascular hypothesis
19. Pathogenesis of rheumatoid arthritis: A vascular hypothesis
20. Mortality in systemic sclerosis (scleroderma)
21. Factors predicting a poor life prognosis in rheumatoid arthritis: An eight year prospective study
22. Plasma and serum von Willebrand Factor antigen levels in connective tissue disorders
23. Mosaic of anti-endothelial cell antibodies. Review of the first International Workshop on Anti-Endothelial Cell Antibodies, Clinical and Pathological Significance
24. Antibody and immune complexes induce tissue factor production by human endothelial cells
25. Stimulation of von Willebrand factor antigen release by immunoglobulin from thrombosis prone patients with systemic lupus erythematosus and the anti-phospholipid syndrome
26. Increased release of von Willebrand factor antigen from endothelial cell by anti-DNA autoantibodies
27. Anti-endothelial cell antibodies: Useful markers of systemic sclerosis
28. Markers of endothelial cell perturbation and damage
29. Von Willebrand factor. A marker of endothelial damage?
30. The natural history of the systemic inflammatory response syndrome
31. IL-8 in septic shock, endotoxaemia and after IL-8 administration
32. Cytokines and plasminogen activator-1 in post-trauma disseminated intravascular coagulation: Relationship to multiple organ dysfunction syndrome
33. Increased plasma von Willebrand factor in the systemic inflammatory response syndrome is derived from generalised endothelial cell activation
34. Time course of hemostatic abnormalities in sepsis and its relation to outcome
35. Considering cellular thrombomodulin distribution and its modulating factors can facilitate the use of plasma thrombomodulin as a reliable endothelial marker
36. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMC infections with organ involvement
37. Endothelial cell dysfunction in HIV infection
38. Von Willebrand factor antigen, tissue type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: Independent prognostic relevance of tissue type plasminogen activator
39. Factor VIII-complex and endothelial damage
40. Hyperlipidaemic endothelial injury and angiogenesis
41. Oxidised LDL damaged endothelial cell monolayer and promotes thrombocyte adhesion
42. The PLAT study: Hemostatic function in relation to atherothrombotic ischaemic events in vascular disease patients. Principal results
43. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
44. Increased levels of plasma thrombomodulin are associated with vascular and all-cause mortality in patients on long term anticoagulant treatment
45. Vascular function in the forearm of hypercholerolaemic patients off and on lipid-lowering medication
46. Influence of smoking on soluble adhesion molecules and endothelial cell markers
47. Von Willebrand factor and soluble E-selectin in hyperlipidaemia: Relationship to vascular disease and the risk factors for atherosclerosis
48. Consensus document: Critical leg ischaemia
49. Membrane thrombomodulin levels are decreased during hypoxia and restored by cAMP and IBMX
50. Smoking
51. Plasma viscosity, fibrinoen and the metabolic syndrome: Effect of obesity and cardiovascular fitness
52. Smoking, haemostatic factors and the severity of aorto-iliac and femoro-popliteal disease
53. Haemostatic and rheological factors in intermittent claudication: The influence of smoking and extent of arterial disease
54. Influence of smoking status on progression of endothelial dysfunction
55. Induction of vascular cell adhesion molecule-1 by low density lipoprotein
56. Native low density lipoprotein increases endothelial cell adhesiveness by inducing ICAM-1
57. Native low density lipoprotein (LDL) induces the expression of the early growth response gene-1 in human umbilical arterial endothelial cells
58. Monocytes and neutrophils oxidise low-density lipoprotein cholesterol making it cytotoxic
59. Atherosclerosis and the two faces of endothelial nitric oxide synthase
60. Concentration of soluble vascular cell adhesion molecule-1 (VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta
61. Adhesion molecules and inflammatory injury
62. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells
63. Potential role of viruses in thrombosis and atherosclerosis
64. Long term follow up of patients with mild coronary artery disease and endothelial dysfunction
65. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes
66. Coronary endothelial dysfunction in the hypertensive patient: From myocardial ischaemia to heart failure
67. An endotoxin-induced serum factor that causes necrosis of tumours
68. C-reactive protein adds to the predictive value of total and HDL-cholesterol in determining risk of first myocardial infarction